CVRx CVRX
NASDAQ CVRX
$2.83 -0.10 (-3.41%)
At close: Sep 9, 2026 · 4:00 PM EDT

CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026)

CVRx (CVRX) posted Total Non-Current Liabilities of $70.1 million for Q2 2026, up 2.37% on a QoQ basis from $68.5 million in Q1 2026, and up 17.1% year-over-year from $59.9 million in Q2 2025.

Analysis

CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

CVRx has reported Total Non-Current Liabilities for 7 years, with the latest figure at $70.1 million in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 17.1% year-over-year to $70.1 million in Q2 2026; TTM through Jun 2026 was $70.1 million, a 17.1% increase from a year earlier, with the FY2025 full-year figure at $63.5 million, up 4.2% from the prior year.
  • Total Non-Current Liabilities was $70.1 million for Q2 2026 at CVRx, up from $68.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $70.1 million in Q2 2026, with the low at $6.2 million in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $40.3 million, with a median of $39.1 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities sank 85.72% in 2022, then surged 291.69% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $15.0 million in 2022, then jumped by 155.79% to $38.2 million in 2023, then soared by 59.26% to $60.9 million in 2024, then grew by 4.2% to $63.5 million in 2025, then rose by 10.52% to $70.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $70.1 million (Q2 2026), $68.5 million (Q1 2026), and $63.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 40.46 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 3.68 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 3.44 Bn
10 CVRx 75.57 Mn 10.98 Mn 13.72 Mn 70.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.14 Mn
Mar 31, 2026 68.52 Mn
Dec 31, 2025 63.47 Mn
Sep 30, 2025 61.40 Mn
Jun 30, 2025 59.90 Mn
Mar 31, 2025 58.64 Mn
Dec 31, 2024 60.91 Mn
Sep 30, 2024 61.11 Mn
Jun 30, 2024 39.47 Mn
Mar 31, 2024 38.76 Mn
Dec 31, 2023 38.25 Mn
Sep 30, 2023 22.62 Mn
Jun 30, 2023 24.12 Mn
Mar 31, 2023 22.23 Mn
Dec 31, 2022 14.95 Mn
Sep 30, 2022 7.57 Mn
Jun 30, 2022 6.16 Mn
Mar 31, 2022 6.90 Mn
Dec 31, 2021 5.91 Mn
Sep 30, 2021 25.00 Mn